Validation of Fluorescence In Situ Hybridization Using an Analyte-Specific Reagent for Detection of Abnormalities Involving the Mixed Lineage Leukemia Gene
Authors:
- Debra F. SaxeDSDebra F. Saxe
- Diane L. PersonsDPDiane L. Persons
- Daynna J. WolffDWDaynna J. Wolff
- Karl S. TheilKTKarl S. Theil
- for the Cytogenetics Resource Committee of the College of American PathologistsFPfor the Cytogenetics Resource Committee of the College of American Pathologists
- 1 January 2012
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 136 (1) , 47-52
Abstract
Context .—Fluorescence in situ hybridization (FISH) is a molecular cytogenetic assay that is commonly used in laboratory medicine. Most FISH assays are not approved by the US Food and Drug Administration but instead are laboratory-developed tests that use analyte-specific reagents. Although several guidelines exist for validation of FISH assays, few specific examples of FISH test validations are available in the literature. Objective .—To provide an example of how a FISH assay, using an analyte-specific reagent probe, may be validated in a clinical laboratory. Design .—We describe the approach used by an individual laboratory for validation of a FISH assay for mixed lineage leukemia ( MLL ) gene. Results .—Specific validation data are provided illustrating how initial assay performance characteristics in a FISH assay for MLL may be established. Conclusions .—Protocols for initial validation of FISH assays may vary between laboratories. However, all laboratories must establish several defined performance specifications prior to implementation of FISH assays for clinical use. We describe an approach used for assessing performance specifications and validation of an analyte-specific reagent FISH assay using probes for MLL rearrangement in interphase nuclei.Keywords
This publication has 11 references indexed in Scilit:
- Statistical Treatment of Fluorescence in Situ Hybridization Validation Data to Generate Normal Reference Ranges Using Excel FunctionsThe Journal of Molecular Diagnostics, 2009
- Preclinical validation of fluorescence in situ hybridization assays for clinical practiceGenetics in Medicine, 2006
- Fluorescence in situ hybridizationNature Methods, 2005
- Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsLeukemia, 2003
- Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridizationCancer Genetics and Cytogenetics, 2000
- Informed consent for medical photographsGenetics in Medicine, 2000
- A DNA probe combination for improved detection ofMLL/11q23 breakpoints by double-color interphase-FISH in acute leukemiasGenes, Chromosomes and Cancer, 2000
- Genetic Testing and the Clinical Laboratory Improvement Amendments of 1988: Present and FutureClinical Chemistry, 1999
- General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997Leukemia, 1998
- Molecular basis of IIq23 rearrangements in hematopoietic malignant proliferationsGenes, Chromosomes and Cancer, 1995